Pete O’Heeron the Chief Executive Officer of SpinalCyte, and he also leads an operational investment group. He has been working in the healthcare industry for the last twenty years, and his investment group identifies early stage opportunities in the medical field with strong intellectual property positions. Through SpinalCyte, he hopes to revolution back surgery procedures by making them safer, less invasive, and creating shorter recovery times for patients. He is primarily serving those with lower back pain or degenerative disc disease.
Pete O’Heeron 